IES20180262A2 - Drug intermediates 3,5-dimethoxybenzaldehyde synthesis method - Google Patents

Drug intermediates 3,5-dimethoxybenzaldehyde synthesis method

Info

Publication number
IES20180262A2
IES20180262A2 IES20180262A IES20180262A2 IE S20180262 A2 IES20180262 A2 IE S20180262A2 IE S20180262 A IES20180262 A IE S20180262A IE S20180262 A2 IES20180262 A2 IE S20180262A2
Authority
IE
Ireland
Prior art keywords
solution
dimethoxybenzaldehyde
added
temperature
synthesis method
Prior art date
Application number
Inventor
Liao Ruer
Original Assignee
Chengdu Ka Di Fu Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Ka Di Fu Tech Co Ltd filed Critical Chengdu Ka Di Fu Tech Co Ltd
Publication of IES20180262A2 publication Critical patent/IES20180262A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention discloses drug intermediates 3,5-dimethoxybenzaldehyde synthesis method, comprises the following steps: 2-bromo-3,5-dimethoxybenzyl alcohol and potassium nitrate solution are added to the reaction vessel, controls the stirring speed, raises the temperature of the solution, and then adds lead tetraacetate powder and aqueous solution, reacts; then 3-methyl pentane solution and rhenium disulfide powder is added, raises the temperature, continues to react, reduces the solution temperature to, sodium sulfate solution is added, put it aside, the solution is stratified, washed with anisole solution, recrystallized from dipropylene glycol solution and dehydrated with dehydration, obtains the finished product 3,5-dimethoxybenzaldehyde. <Figure 1>
IES20180262 2017-09-07 2018-08-23 Drug intermediates 3,5-dimethoxybenzaldehyde synthesis method IES20180262A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710781785.4A CN108264453A (en) 2017-09-07 2017-09-07 The synthetic method of pharmaceutical intermediate 3,5- dimethoxy benzaldehydes

Publications (1)

Publication Number Publication Date
IES20180262A2 true IES20180262A2 (en) 2019-11-13

Family

ID=60117383

Family Applications (1)

Application Number Title Priority Date Filing Date
IES20180262 IES20180262A2 (en) 2017-09-07 2018-08-23 Drug intermediates 3,5-dimethoxybenzaldehyde synthesis method

Country Status (4)

Country Link
CN (1) CN108264453A (en)
AU (1) AU2018101125A4 (en)
GB (1) GB201714447D0 (en)
IE (1) IES20180262A2 (en)

Also Published As

Publication number Publication date
GB201714447D0 (en) 2017-10-25
AU2018101125A4 (en) 2018-09-13
CN108264453A (en) 2018-07-10

Similar Documents

Publication Publication Date Title
IES20180262A2 (en) Drug intermediates 3,5-dimethoxybenzaldehyde synthesis method
IE20180280U1 (en) Methylchloroperoxybenzoic acid drug intermediates synthesis method
IE20180281U1 (en) Benzoyl peroxide organic intermediates synthesis method
IES20180253U1 (en) Tert-butyl hydroperoxide drug intermediates synthesis method
IE20180288U1 (en) P-methoxphenylacetic acid drug intermediates synthesis method
IES20180267U1 (en) Aminoquinone drug intermediates tetrachlorobenzoquinone synthesis method
IES20180244U1 (en) Rubber cross-linking agent cyclohexanone peroxide synthesis method
IES20180266A2 (en) 2-furanacrylic acid drug intermediates synthesis method
IES20180293A2 (en) 1,2-naphthoquinone drug intermediates synthesis method
IE20180282U1 (en) Dodecanoyl peroxide organic intermediates synthesis method
IES20180251U1 (en) Nicotinamide-n-oxide drug intermediates synthesis method
IE20180290U1 (en) P-aminobenzaldehyde drug intermediates synthesis method
IES20180277U1 (en) Organic intermediate 1,6-cyclohexanedione synthesis method
IES20180263A2 (en) Drug intermediates 3-methoxy-2-thiophenecarboxaldehyde synthesis method
IES20180242U1 (en) Broad spectrum antimicrobial agents thiamphenicol synthesis method
IES20180245U1 (en) Broad spectrum fungcide peracetic acid synthesis method
IES20180195A2 (en) Pharmaceutical hormone intermediates 11-ketone-16α, 17α-epoxy progesterone synthesis method
IES20180204A2 (en) Organic intermediates oxalic acid aldehydes synthesis method
IE20180289U1 (en) 2-nitro-4-aminobenzaldehyde drug intermediates synthesis method
IE20180283U1 (en) O-toluene formamide organic intermediates synthesis method
IES20180250A2 (en) Butyraldehyde oxime drug itermediates synthesis method
IES20180200A2 (en) Anti-clavicular spirochete drugs ethyl imidazole synthesis method
IES20180261A2 (en) Drug intermediates 3,4,5-trimethoxybenzaldehyde synthesis method
IES20180102A2 (en) Organic synthesis intermediates N-propenyl urea synthesis method
IES20180260U1 (en) Drug intermediates 1-methyl-2-quinolinone synthesis method

Legal Events

Date Code Title Description
FJ9A Application deemed to be withdrawn section 31(3)